fashion -WSS

fashion

author：fashion 2025-08-25 07:27:18 - browse：26351

Red blood cells flow in an artery biotech — coverage from STAT — Adobe

PHILADELPHIA — An investigational drug aimed at preventing strokes significantly reduced the risk of bleeding compared with a commonly used blood thinner for stroke prevention, showing potential to be a safer alternative for patients.

Among patients with atrial fibrillation, an abnormal heart rhythm that increases the risk of stroke, abelacimab, developed by Anthos Therapeutics, cut the overall risk of bleeding by 67% compared to rivaroxaban, the blood thinner sold as Xarelto by Janssen Pharmaceuticals.

The treatment, injected monthly, also reduced the risk of major bleeding events by 74% and gastrointestinal bleeding by 93%, according to Phase 2 results presented here Sunday at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Heart disease in astronauts blamed on cosmic radiation

WSS

Neuroscience startup Neumora files for IPO

Medicare explains how it will choose drugs for negotiation

Medicare explains how it will choose drugs for negotiation

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Neuroscience startup Neumora files for IPO

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

explore

fashion

entertainment

Sports medicine is finally prioritizing gender equality

How to make AI work for medicine

Tori Bowie and the unacceptable rates of Black maternal death

CDC advisory panel says seniors 'may' get RSV vaccine

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FDA scientists endorse Pfizer/BioNTech Covid

Peter Hotez and the public health issue of online harassment

Diversity in medical illustrations gets boost from Chidiebere Ibe

State Dept. review finds Biden bears some blame for Afghanistan failures

Complete sequence of Y chromosome published for first time

explore

AstraZeneca bets AAV gene therapy will still deliver the goods

It costs an awful lot of money to give away a kidney

Study links childhood stress with decline in older age

FDA scientists endorse Pfizer/BioNTech Covid

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Biotech startup Celsius cuts 75% of staff ahead of first trial start

entertainment

knowledge

leisure time

focus